Characterisation of DNA methylation biomarkers for bladder cancer;Charakterisierung von DNA-Methylierungs-Biomarkern für das Harnblasenkarzinom

Pathologe

Volumn 31, Issue SUPPL. 2, 2010, Pages 244-250

  Antony, P ^a   Rose, M ^a   Gaisa, N T ^a   Alkaya, S ^a   Heidenreich, A ^b   Knuchel R ^a   Dahl, E ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Bladder cancer; DNA methylation biomarkers; Early diagnosis; Epigenetics; SFRP5

Indexed keywords

EYE PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; SFRP5 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BLADDER; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; CHROMOSOME DELETION; DNA METHYLATION; EARLY DIAGNOSIS; EPIGENETICS; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CHROMOSOME DELETION; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; EPIGENOMICS; EYE PROTEINS; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 79953167229     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1367-1     Document Type: Article

References (24)

1. Bischoff CJ, Clark PE (2009) Bladder cancer. Curr Opin Oncol 21:272-277
2. Chan MW, Chan LW, Tang NL et al (2003) Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Int J Cancer 104:611-616
3. Dulaimi E, Uzzo RG, Greenberg RE et al (2004) Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res 10:1887-1893
4. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148-1159
5. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8:286-298
6. Esteller M, Corn PG, Baylin SB et al (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229
7. Friedrich MG, Weisenberger DJ, Cheng JC et al (2004) Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res 10:7457-7465
8. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054
9. Hoque MO, Begum S, Topaloglu O et al (2006) Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 98:996-1004
10. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
11. Kim YK, Kim WJ (2009) Epigenetic markers as promising prognosticators for bladder cancer. Int J Urol 16:17-22
12. Knowles MA (2006) Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27:361-373
13. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820-823
14. Lee MG, Kim HY, Byun DS et al (2001) Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res 61:6688-6692
15. Mann B, Gelos M, Siedow A et al (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96:1603-1608
16. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
17. Shanks JH, Iczkowski KA (2009) Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology 54:885-900
18. Steiner G, Schoenberg MP, Linn JF et al (1997) Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 3:621-624
19. Suzuki H, Toyota M, Carraway H et al (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98:1147-1156
20. Urakami S, Shiina H, Enokida H et al (2006) Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 12:2109-2116
21. Veeck J, Geisler C, Noetzel E et al (2008) Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis 29:991-998
22. Vrooman OP, Witjes JA (2008) Urinary markers in bladder cancer. Eur Urol 53:909-916
23. Wild PJ, Herr A, Wissmann C et al (2005) Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 11:4415-4429
24. Yates DR, Rehman I, Abbod MF et al (2007) Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 13:2046-2053